首页> 外国专利> Preparation method for eutectic hydrate crystal form II of AHU-377 and diovan trisodium salt

Preparation method for eutectic hydrate crystal form II of AHU-377 and diovan trisodium salt

机译:AHU-377共晶水合物晶型Ⅱ和二恶英三钠盐的制备方法

摘要

The present disclosure relates to a preparation method of a trisodium AHU-377 and Valsartan co-crystal hydrate Form II. The preparation method comprises: firstly, preparing a clear solution of trisodium AHU-377 and Valsartan, the solvent of the clear solution comprises an anti-solvent and a good solvent of the target product Form II, and the boiling point of the good solvent is lower than that of the anti-solvent; secondly, evaporating the solution under vacuum to remove the good solvent and water from the system; and finally, optionally adding seed crystals of Form II or not and replenishing a mixture of water and a carrier solvent for stirring for crystallization. The method of the present disclosure can prepare Form II successfully, and the process is consistent and controllable. The obtained Form II product has high chemical purity, crystalline purity and good flowability; and the process can be scaled up, and meets the requirements of large-scale production.
机译:本发明涉及AHU-377三钠与缬沙坦二晶水合物晶型II的制备方法。制备方法包括:首先,制备AHU-377三钠和缬沙坦的澄清溶液,该澄清溶液中的溶剂包括目标产物晶型II的抗溶剂和良溶剂,良溶剂的沸点为低于抗溶剂;其次,在真空下蒸发溶液以从系统中除去良溶剂和水。最后,任选地添加或不添加形式II的晶种,并补充水和载体溶剂的混合物以搅拌以结晶。本公开的方法可以成功地制备晶型II,并且该过程是一致且可控的。所得的II型产物具有较高的化学纯度,结晶纯度和良好的流动性。可以扩大规模,满足大规模生产的要求。

著录项

  • 公开/公告号US10442775B2

    专利类型

  • 公开/公告日2019-10-15

    原文格式PDF

  • 申请/专利权人 CRYSTAL PHARMATECH CO. LTD.;

    申请/专利号US201616060909

  • 发明设计人 MINHUA CHEN;YANFENG ZHANG;LIANG ZHANG;

    申请日2016-11-10

  • 分类号C07D257/04;C07C231/24;C07C233/47;A61P9/04;

  • 国家 US

  • 入库时间 2022-08-21 12:16:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号